SCHEMBL29603602

SCHEMBL29603602

CCOC(=O)c1cc(Br)cnc1C=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 6/20 0.46
▸ TSHR P16473 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14054179 1.00 OPRK1 (0.46) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL18765932 0.83 OPRK1 (0.47) OPRK1
SCHEMBL5864153 0.81 OPRK1 (0.50) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL15527494 0.81 OPRK1 (0.50) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL10668140 0.80 OPRK1 (0.49) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL15540688 0.79 KDM4E (0.44) TSHRNPSR1POLBHSD17B10MEN1
SCHEMBL1887152 0.79 CHEK2 (0.56) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL15527865 0.79 OPRK1 (0.48) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL20472328 0.79 OPRK1 (0.48) OPRK1TSHRNPSR1POLBHSD17B10
SCHEMBL18398582 0.79 OPRK1 (0.48) OPRK1TSHRNPSR1POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983074-A1 PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-04-20 — — EP disclosed
Send feedback